BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27773554)

  • 41. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
    Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Striatal histamine mechanism in the pathogenesis of restless legs syndrome.
    Lai YY; Hsieh KC; Cheng YH; Chew KT; Nguyen D; Ramanathan L; Siegel JM
    Sleep; 2020 Feb; 43(2):. PubMed ID: 31671173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents.
    Massart R; Guilloux JP; Mignon V; Sokoloff P; Diaz J
    Eur J Neurosci; 2009 Aug; 30(3):397-414. PubMed ID: 19656174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the Histamine H
    Schlicker E; Kathmann M
    Handb Exp Pharmacol; 2017; 241():277-299. PubMed ID: 27787717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histamine modulation of the basal ganglia circuitry in the development of pathological grooming.
    Rapanelli M; Frick L; Bito H; Pittenger C
    Proc Natl Acad Sci U S A; 2017 Jun; 114(25):6599-6604. PubMed ID: 28584117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential dopaminergic regulation of inwardly rectifying potassium channel mediated subthreshold dynamics in striatal medium spiny neurons.
    Zhao B; Zhu J; Dai D; Xing J; He J; Fu Z; Zhang L; Li Z; Wang W
    Neuropharmacology; 2016 Aug; 107():396-410. PubMed ID: 27018450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a Conformational Histamine H
    Schihada H; Ma X; Zabel U; Vischer HF; Schulte G; Leurs R; Pockes S; Lohse MJ
    ACS Sens; 2020 Jun; 5(6):1734-1742. PubMed ID: 32397705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homeostatic regulation of excitatory synapses on striatal medium spiny neurons expressing the D2 dopamine receptor.
    Thibault D; Giguère N; Loustalot F; Bourque MJ; Ducrot C; El Mestikawy S; Trudeau LÉ
    Brain Struct Funct; 2016 May; 221(4):2093-107. PubMed ID: 25782435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptor and Ionic Mechanism of Histamine on Mouse Dorsolateral Striatal Neurons.
    Peng JY; Shen KL; Fan XJ; Qi ZX; Huang HW; Jiang JL; Lu JH; Wang XQ; Fang XX; Yuan WR; Deng QX; Chen S; Chen L; Zhuang QX
    Mol Neurobiol; 2023 Jan; 60(1):183-202. PubMed ID: 36245064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat.
    Giannoni P; Passani MB; Nosi D; Chazot PL; Shenton FC; Medhurst AD; Munari L; Blandina P
    Eur J Neurosci; 2009 Jun; 29(12):2363-74. PubMed ID: 19490084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol.
    Sadek B; Shehab S; Więcek M; Subramanian D; Shafiullah M; Kieć-Kononowicz K; Adem A
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4886-91. PubMed ID: 23891186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of histamine H3 receptor agonist and antagonist on histamine co-transmitter expression in rat brain.
    Chotard C; Ouimet T; Morisset S; Sahm U; Schwartz JC; Trottier S
    J Neural Transm (Vienna); 2002 Mar; 109(3):293-306. PubMed ID: 11956952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The other side of the histamine H3 receptor.
    Ellenbroek BA; Ghiabi B
    Trends Neurosci; 2014 Apr; 37(4):191-9. PubMed ID: 24636456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of the ileal neuroendocrine tumor cell line P-STS by acetylcholine is amplified by histamine: role of H3R and H4R.
    Pfanzagl B; Mechtcheriakova D; Meshcheryakova A; Aberle SW; Pfragner R; Jensen-Jarolim E
    Sci Rep; 2017 May; 7(1):1313. PubMed ID: 28465562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histamine H3 and H4 receptors as novel drug targets.
    Tiligada E; Zampeli E; Sander K; Stark H
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases.
    Sadek B; Saad A; Sadeq A; Jalal F; Stark H
    Behav Brain Res; 2016 Oct; 312():415-30. PubMed ID: 27363923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histamine H3 receptor activation inhibits dopamine synthesis but not release or uptake in rat nucleus accumbens.
    Aquino-Miranda G; Escamilla-Sánchez J; González-Pantoja R; Bueno-Nava A; Arias-Montaño JA
    Neuropharmacology; 2016 Jul; 106():91-101. PubMed ID: 26169221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homogeneous, Real-Time NanoBRET Binding Assays for the Histamine H
    Mocking TAM; Verweij EWE; Vischer HF; Leurs R
    Mol Pharmacol; 2018 Dec; 94(6):1371-1381. PubMed ID: 30249614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Determinant Underlying Selective Coupling of Primary G-Protein by Class A GPCRs.
    Shen Q; Tang X; Wen X; Cheng S; Xiao P; Zang SK; Shen DD; Jiang L; Zheng Y; Zhang H; Xu H; Mao C; Zhang M; Hu W; Sun JP; Zhang Y; Chen Z
    Adv Sci (Weinh); 2024 Jun; 11(23):e2310120. PubMed ID: 38647423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.